Pluristem Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/09/2022 | Q3 2022 | -$0.36 | -$0.31 | 0.05 | $234,000 | |
| 02/07/2022 | Q2 2022 | -$0.38 | -$0.34 | 0.04 | $0 | |
| 11/08/2021 | Q1 2022 | -$0.41 | -$0.36 | 0.05 | $0 | |
| 09/13/2021 | Q4 2021 | -$0.40 | -$0.49 | -0.09 | $0 | |
| 05/06/2021 | Q3 2021 | -$0.33 | -$0.48 | -0.15 | $0 | |
| 02/08/2021 | Q2 2021 | -$0.26 | -$0.49 | -0.23 | $0 | |
| 11/05/2020 | Q1 2021 | -$0.10 | -$0.33 | -0.23 | $0 | |
| 09/10/2020 | Q4 2020 | -$0.36 | -$0.32 | 0.04 | $0 | |
| 05/11/2020 | Q3 2020 | -$0.36 | -$0.42 | -0.06 | $0 | |
| 02/06/2020 | Q2 2020 | -$0.52 | -$0.40 | 0.12 | $23,000 | |
| 11/07/2019 | Q1 2020 | -$0.66 | -$0.46 | 0.2 | $0 | |
| 09/12/2019 | Q4 2019 | -$0.63 | -$0.50 | 0.13 | $0 | |
| 05/06/2019 | Q3 2019 | -$0.75 | -$0.86 | -0.11 | $0 | |
| 02/06/2019 | Q2 2019 | -$0.85 | -$0.75 | 0.1 | $50,000 | |
| 11/07/2018 | Q1 2019 | -$0.90 | -$0.77 | 0.13 | $4,000 | |
| 09/12/2018 | Q4 2018 | -$0.70 | -$0.79 | -0.09 | $0 | |
| 05/09/2018 | Q3 2018 | -$0.90 | -$0.14 | 0.76 | $0 | |
| 02/06/2018 | Q2 2018 | -$0.80 | -$0.78 | 0.02 | $50,000 | |
| 11/07/2017 | Q1 2018 | -$0.83 | -$0.76 | 0.07 | $0 | |
| 09/07/2017 | Q4 2017 | -$0.90 | -$0.72 | 0.18 | $0 |
Pluristem Therapeutics Inc. Earnings: Frequently Asked Questions
-
When is Pluristem Therapeutics Inc.'s earnings date?
Pluristem Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, September 12th, 2022 based off last year's report dates.
-
How can I listen to Pluristem Therapeutics Inc.'s earnings conference call?
The conference call for Pluristem Therapeutics Inc.'s latest earnings report can be listened to online.
-
How can I read Pluristem Therapeutics Inc.'s conference call transcript?
The conference call transcript for Pluristem Therapeutics Inc.'s latest earnings report can be read online.
-
How much profit does Pluristem Therapeutics Inc. generate each year?
Pluristem Therapeutics Inc. (:PSTI) has a recorded net income of $0. Pluristem Therapeutics Inc. has generated $-1.77 earnings per share over the last four quarters.
-
What is Pluristem Therapeutics Inc.'s price-to-earnings ratio?
Pluristem Therapeutics Inc. (:PSTI) has a price-to-earnings ratio of -0.56 and price/earnings-to-growth ratio is 0.05.
